Evaluation and Management of Nonculprit Lesions in STEMI

JACC Cardiovasc Interv. 2020 May 25;13(10):1145-1154. doi: 10.1016/j.jcin.2020.02.030.

Abstract

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

Keywords: CFR; FFR; STEMI; iFR; nonculprit coronary lesions.

Publication types

  • Review

MeSH terms

  • Clinical Decision-Making
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / therapy*
  • Coronary Circulation
  • Coronary Stenosis / diagnostic imaging
  • Coronary Stenosis / physiopathology
  • Coronary Stenosis / therapy*
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Recovery of Function
  • Recurrence
  • Risk Factors
  • ST Elevation Myocardial Infarction / diagnostic imaging
  • ST Elevation Myocardial Infarction / physiopathology
  • ST Elevation Myocardial Infarction / therapy*
  • Severity of Illness Index
  • Treatment Outcome